日韩免费视频中文在线观看-国产成人在线视频一区二区三区-天天做天天爱天天大爽-欧美α片无限看在线观看免费-日本肥熟老熟妇15p-日本中文字幕三级在线视频-成人不卡视频在线观看-日韩一区二区三区无码人妻视频-青青草绿色视频在线观看

歡迎您訪問武漢艾美捷科技有限公司官方網(wǎng)站!
站點(diǎn)地圖 服務(wù)熱線:400-6800-868
  • 產(chǎn)品
  • 文章

PRODUCT CENTER

二抗
產(chǎn)品中心

當(dāng)前位置:首頁 > 產(chǎn)品中心 > 免疫學(xué)產(chǎn)品 > 二抗

中文名稱

Mogamulizumab 生物類似藥, CCR4 單克隆抗體

英文名字
Mogamulizumab Biosimilar, CCR4 Monoclonal Antibody
供應(yīng)商
Promab
產(chǎn)品貨號(hào)
PMB-B00046
產(chǎn)品報(bào)價(jià)
¥詢價(jià)/1mg/5mg/20mg
產(chǎn)品說明書
點(diǎn)擊查看
購買方式
90%產(chǎn)品中國有現(xiàn)貨庫存。銀行轉(zhuǎn)賬、電匯、支票、現(xiàn)金,在線支付寶及網(wǎng)銀支付,或直接與我們電話聯(lián)系400-6800-868
產(chǎn)品新聞
背景資料
Mogamulizumab Biosimilar uses the same protein sequences as the therapeutic antibody mogamulizumab.nnMogamulizumab is a humanized monoclonal antibody (mAb) directed against CC chemokine receptor 4 (CCR4) for the treatment of Mycosis Fungoides (MF) and Sézary Syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma. Cutaneous T-cell lymphomas occur when certain white blood cells, called T cells, become cancerous; these cancers typically affect the skin, causing various types of skin lesions.nnMogamulizumab is derived from Kyowa Hakko Kirin's POTELLIGENT technology, which produces antibodies with enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity.nnMogamulizumab selectively binds to and inhibits the activity of CCR4, which may block CCR4-mediated signal transduction pathways and, so, chemokine-mediated cellular migration and proliferation of T cells, as well as chemokine-mediated angiogenesis. Additionally, this agent may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against CCR4-positive T cells. CCR4, a G-coupled-protein receptor for C-C chemokines such MIP-1, RANTES, TARC and MCP-1, is expressed on the surfaces of some types of T cells, endothelial cells, and certain types of neurons. CCR4, also known as CD194, may be overexpressed on adult T-cell lymphoma (ATL) and peripheral T-cell lymphoma (PTCL) cells. In addition to directly targeting malignant T cells expressing CCR4, mogamulizumab depletes Treg cells, an important therapeutic target in many human cancers because of their role in suppressing host antitumor immunity.
應(yīng)用類型
Flow cytometry, animal model study
免疫原
Human CCR4
來源宿主
CHO cells
反應(yīng)性
Human
保存建議
Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
其他
CC chemokine receptor type 4, CC-CKR-4, CD194, CKR4, CMKBR4, ChemR13, HGCN:14099, K5-5, C-C motif chemokine receptor 4
注意
該頁面的中文產(chǎn)品信息的翻譯,僅供參考。準(zhǔn)確的產(chǎn)品信息請(qǐng)以廠家的英文說明書為準(zhǔn)。下單前,請(qǐng)瀏覽說明書確認(rèn)。
在線留言
產(chǎn)品分類
特色產(chǎn)品 MORE
最近促銷 MORE
  • 高品質(zhì)保障 成熟的生產(chǎn)研發(fā)技術(shù)
  • 高性價(jià)比 價(jià)宜質(zhì)優(yōu),性價(jià)比高
  • 高效省心 從購買到使用,放心無憂
  • 安全運(yùn)輸 完善的保護(hù)措施安全運(yùn)輸

微信掃碼在線客服

微信咨詢

全國免費(fèi)技術(shù)支持

400-6800-868

在線客服